Amy Shapiro
Pediatric Hematology-Oncology · Indianapolis, INNPI 1942380274
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $201,001 of the $287,421 with a category attached, or 69.9%. It is spread thinly across 17 manufacturers, the largest accounting for just 22.7%. Among pediatric hematology-oncology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $2177.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$65K
- Novo Nordisk Health Care AG$57K
- Kedrion S.p.a.$50K
- Genentech USA, Inc.$36K
- Sanofi$30K
- F. Hoffmann-la Roche AG$13K
- plus $35K from 11 others
Across 1,698 payments — averaging $1221.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$447K
- Genentech, Inc.$405K
- Servier Bioinnovation$383K
- Pfizer$213K
- Kedrion S.p.a.$202K
- Agios Pharmaceuticals, Inc.$132K
- plus $293K from 11 others
What the payments were for
- Consulting fees$201,00170%
- Speaking & faculty fees$60,79721%
- Travel & lodging$23,9228%
- Food & beverage$1,5031%
- Education$1860%
- Gifts$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 34 | $65,155 |
| Novo Nordisk Health Care AG | 22 | $57,272 |
| Kedrion S.p.a. | 4 | $50,085 |
| Genentech USA, Inc. | 23 | $36,474 |
| Sanofi | 11 | $29,619 |
| F. Hoffmann-la Roche AG | 10 | $13,414 |
| Biomarin Pharmaceutical Inc. | 3 | $7,662 |
| Bioverativ Therapeutics Inc. | 8 | $7,610 |
| Novo Nordisk AS | 2 | $4,400 |
| Sanofi US Services Inc. | 1 | $4,311 |
| CSL Behring | 4 | $3,299 |
| HEMA Biologics, LLC | 5 | $3,012 |
| Bio Products Laboratory USA, Inc. | 1 | $2,250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $2,025 |
| Genentech, Inc. | 1 | $808 |
| Mayne Pharma Commercial LLC | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$287,421 in reported general payments places this provider in the 95th percentile of 59 pediatric hematology-oncology providers in Indiana.
See all pediatric hematology-oncology providers in Indiana →
Other pediatric hematology-oncology in Indianapolis
- Sanjay AhujaIndianapolis$197K
- Bassem RazzoukIndianapolis$42K
- Melissa BearIndianapolis$26K
- Steven RhodesIndianapolis$13K
- Kyle DavisIndianapolis$10K
- Seethal JacobIndianapolis$8K
- Charles NakarIndianapolis$5K
- Scott CovenIndianapolis$4K
- Sandeep BatraIndianapolis$4K
- Kerry HegeIndianapolis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.